isradipine   Click here for help

GtoPdb Ligand ID: 4488

Synonyms: (±)-isradipine | DynaCirc® | PN-200-110 | Prescal®
Approved drug
isradipine is an approved drug (FDA (1990))
Compound class: Synthetic organic
Comment: The approved drug isradipine is a racemic mixture of (+)-isradipine and (-)-isradipine. We show the non-stereo molecule to represent the mixture.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: isradipine

isradipine is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 103.55
Molecular weight 371.15
XLogP 4.95
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
Isomeric SMILES COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
InChI InChI=1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3
InChI Key HMJIYCCIJYRONP-UHFFFAOYSA-N
Bioactivity Comments
Due to the complex nature of this drug's MMOA, and the paucity of (human) affinity data, we do not tag a primary drug target.
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Cav1.4 Hs Gating inhibitor Antagonist - - 1x10-6 3
⤷ Conc range: 1x10-6 M [3]
Voltage: -90.0 – -50.0 mV
Cav1.3 Hs Gating inhibitor - - - 3x10-8 - 3x10-7 2
⤷ Conc range: 3x10-8 - 3x10-7 M [2]
Voltage: -90.0 – -50.0 mV
Cav1.2 Hs Gating inhibitor Antagonist 8.5 – 8.8 pIC50 - 4
⤷ pIC50 8.8 arterial smooth muscle-like activity [4]
pIC50 8.5 dopamine neuron neuron-like activity [4]
Cav1.3 Hs Gating inhibitor - 7.8 – 9.3 pIC50 - 4,6
⤷ pIC50 9.3 (IC50 5.1x10-10 M) [6]
Description: Recombinant Cav1.3 calcium channel complexes expressed in tsA201-cells
pIC50 7.8 – 8.2 dopamine neuron-like activity; splice variant-dependent [4]
Cav1.2 Mm Gating inhibitor Antagonist 7.5 pIC50 - 5
⤷ pIC50 7.5 [5]
Voltage: -80.0 mV
Cav1.4 Mm Gating inhibitor Antagonist 6.7 pIC50 - 1
⤷ pIC50 6.7 [1]
Voltage: -80.0 mV